Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis

Comprehensive Psychiatry

Volumn 53, Issue 8, 2012, Pages 1063-1070

  Rubio, Gabriel ^a,b,c   Marín Lozano, Jesús ^d   Ferre, Francisco ^b,e   Martínez Gras, Isabel ^a,b,c   Rodriguez Jimenez, Roberto ^a,b,c   Sanz, Javier ^a,b,c   Jimenez Arriero, Miguel Angel ^a,b,c   Carrasco, José Luis ^b,c,f   Lora, David ^a   Jurado, Rosa ^a,c   López Trabada, José Ramón ^a   Palomo, Tomás ^a,b,c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ADULT; ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; CANNABIS INDUCED PSYCHOTIC DISORDER; DELUSIONAL DISORDER; DEPRESSION; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PERSONALITY DISORDER; PHOBIA; PSYCHOPATHY; PSYCHOSIS; SYMPTOM CHECKLIST 90;

ADULT; AWARENESS; CANNABINOIDS; COMORBIDITY; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; PATIENT ADMISSION; PHOBIC DISORDERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SPAIN; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84868199865     PISSN: 0010440X     EISSN: 15328384     Source Type: Journal    
DOI: 10.1016/j.comppsych.2012.04.013     Document Type: Article

References (55)

1. European Monitoring Centre for Drugs, Drug Addiction (EMCDDA) An overview of cannabis potency in Europe. EMCDDA Insights 2004 Office for Official Publications of the European Communities Luxembourg
2. A. Hughes, N. Sathe, and K. Spagnola State estimates of substance use from the 2005-2006 National Surveys on Drug Use and Health DHHS Publication No. SMA-08-4311, NSDUH Series H-33 2008 Substance Abuse and Mental Health Services Administration, Office of Applied Studies Rockville MD
3. Observatorio Español sobre Drogas (OED) Inform 2004: trends on substance use in Spain 2004 Ministerio de Sanidad Delegación del Gobierno para el Plan Nacional sobre Drogas. Madrid 2005
4. R.E. Drake, M.A. Wallach, and J.S. Hoffman Housing instability and homelessness among aftercare patients of an urban state hospital Hosp Community Psychiatry 40 1989 46 51 (Pubitemid 19029898)
5. D.C. Mathers, and B.H. Ghodse Cannabis and psychotic illness Br J Psychiatry 161 1992 648 653
6. L. Dixon Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes Schizophr Res 35 1999 S93 S100
7. J.C. Negrete Clinical aspects of substance abuse in persons with schizophrenia Can J Psychiatry 48 2003 14 21 (Pubitemid 36331415)
8. A. Johns Psychiatric effects of cannabis Br J Psychiatry 178 2001 116 122 (Pubitemid 32158073)
9. J. van Os, M. Bak, M. Hanssen, R.V. Bijl, R. de Graaf, and H. Verdoux Cannabis use and psychosis: a longitudinal population-based study Am J Epidemiol 156 2002 319 327 (Pubitemid 34857999)
10. D. Caspari Cannabis and schizophrenia: results of a follow-up study Eur Arch Psychiatr Clin Neurosci 249 1999 45 49 (Pubitemid 29366776)
11. B. Kovasznay, J. Fleischer, M. Tanenberg-Karant, L. Jandorf, A.D. Miller, and E. Bromet Substance use disorder and the early course of illness in schizophrenia and affective psychosis Schizophr Bull 23 1997 195 201 (Pubitemid 27224872)
12. J.C. Negrete, W.P. Knapp, D.E. Douglas, and W.B. Smith Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey Psychol Med 16 1986 515 520 (Pubitemid 17189451)
13. F. Smit, L. Bolier, and P. Cuijpers Cannabis use and the risk of later schizophrenia: a review Addiction 99 2004 425 430 (Pubitemid 38496658)
14. M.C. Jockers-Scherübl, T. Wolf, N. Radzei, P. Schlattman, J. Rentzsch, and A. Gómez-Carrilo Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls Prog Neuropsychopharmacol Biol Psychiatry 31 2007 1054 1063
15. R. Rodríguez-Jiménez, A. Bagney, I. Martínez-Gras, G. Ponce, E.M. Sánchez-Morla, and M. Aragües Executive function in schizophrenia: influence of substance use disorder history Schizophr Bull 118 2010 34 40
16. N. Boutros, and M.B. Bowers Chronic substance-induced psychotic disorders: state of the literature J Neuropsychiatry 8 1996 262 269 (Pubitemid 26275736)
17. A. Agrawal, J.I. Nurnberger Jr., and M.T. Lynskey Cannabis involvement in individuals with bipolar disorder Psychiatry Res 185 2011 459 461
18. M. Tohen, E. Vieta, A. Gonzalez-Pinto, C. Reed, D. Lin European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Advisory Board Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania J Clin Psychiatry 71 2010 255 261
19. M. van Laar, S. van Dorsselaer, K. Monshouwer, and R. de Graaf Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? Addiction 102 2007 1251 1260 (Pubitemid 47037929)
20. M. De Hert, M. Wampers, T. Jendricko, T. Franic, D. Vidovic, and N. De Vriendt Effects of cannabis use on age at onset in schizophrenia and bipolar disorder Schizophr Res 126 2011 270 276
21. S.M. Strakowski, M.P. DelBello, D.E. Fleck, C.M. Adler, R.M. Anthenelli, and P.E. Keck Jr. Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania Arch Gen Psychiatry 64 2007 57 64 (Pubitemid 46041739)
22. I. van Rossum, M. Boomsma, D. Tenback, C. Reed, and J. van Os EMBLEM Advisory Board. Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis J Nerv Ment Dis 197 2009 35 40
23. C.L.M. Caton, R.E. Drake, D.S. Hasin, B. Dominguez, P. Shrout, and S. Samet Differences between early phase primary psychotic disorders with concurrent substance use and substance-induced psychosis Arch Gen Psychiatry 62 2005 137 145 (Pubitemid 40189129)
24. M. Berk, S. Brook, and A.I. Trandafir A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double blind randomized controlled trial Int Clin Psychopharmacol 14 1999 177 180 (Pubitemid 29348771)
25. S. Fraser, L. Hides, L. Philips, D. Proctor, and D.I. Lubman Differentiating first episode substance induced and primary psychotic disorders with concurrent substance use in young people Schizophr Res 136 2012 110 115
26. L.A. Nuñez, and M. Gurpegui Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia Acta Psychiatr Scand 105 2002 173 178 (Pubitemid 34280689)
27. M. Arendt, R. Rosenberg, L. Foldager, G. Perto, and P. Munk-Jorgensen Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases Br J Psychiatry 187 2005 510 515 (Pubitemid 41752739)
28. L.R. Derogatis SCL-90-R Cuestionario de 90 síntomas. Manual (Adaptation by Gónzalez de Rivera JL) 2002 Tea Ediciones Madrid
29. L.R. Derogatis SCL-90-R, administration, scoring and procedures manual for the revised version 1977 John Hopkins University, School of Medicine Baltimore
30. X.F. Amador, D.H. Strauss, S. Yale, J.M. Gorma, and J. Endicott The assessment of insight in psychosis Am J Psychiatry 150 1993 873 879
31. D.S. Hasin, K.D. Trautman, G.M. Miele, S. Samet, M. Smith, and J. Endicott Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers Am J Psychiatry 153 1996 1195 1201 (Pubitemid 26299841)
32. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed 1994 American Psychiatric Press Wahington DC 1994
33. M. Torrens, D. Serrano, M. Astais, G. Perez-Dominguez, and R. Martin-Santos Diagnosing psychiatric comorbidity in substance abusers. Validity of the Spanish versions of Psychiatric Research Interview for Substance and Mental Disorders (PRISM-IV) and the Structured Clinical Interview for DSM-IV (SCID-IV) Am J Psychiatry 161 2004 1231 1237 (Pubitemid 38859173)
34. M.B. First, M. Gibbon, R.L. Spitzer, J.B. Williams, and L. Benjamin Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) 1997 Biometrics Research Institute, New York State Psychiatric Institute New York
35. J.L. Fleiss Statistical methods for rates and proportions 2nd ed 1981 John Wiley and Sons New York
36. D.L. Simel, G.P. Samsa, and D.B. Matchar Likelihood ratios with confidence: sample size estimation for diagnostic test studies J Clin Epidemiol 44 1991 763 770
37. T.G. Clark, M.J. Bradburn, S.B. Love, and D.G. Altman Survival analysis part IV, further concepts and methods in survival analysis Br J Cancer 89 2003 781 786 (Pubitemid 37175795)
38. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36 (Pubitemid 12142173)
39. N.J.D. Nagelkerke A note on a general definition of the coefficient of determination Biometrika 78 1991 691 692
40. G. Bedi, N.T. Van Dam, and J. Redman Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use J Psychopharmacol 24 2010 233 240
41. D.C. D'Souza, E. Perry, L. MacDougall, Y. Ammerman, T. Cooper, and Y.T. Wu The psichotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis Neuropsychopharmacology 29 2004 1558 1572 (Pubitemid 38982249)
42. G. Rubio Cannabis use in different groups J. Cabrera, Cannabis. Hasta Dónde 1999 Harcourt Madrid 167 184
43. H. Thomas Psychiatric symptoms in cannabis users Br J Psychiatry 163 1993 141 149 (Pubitemid 23233080)
44. J.A. Crippa, A.W. Zuardi, R. Martin-Santos, S. Bhattacharyya, Z. Atakan, and P.H. McGuire Cannabis and anxiety: a critical review of the evidence Hum Psychopharmacol Clin Exp 24 2009 515 523
45. D. Freeman, M. Gittins, K. Pugh, A. Antloy, A. Slater, and G. Dunn What makes one person paranoid and another person anxious? The differential prediction of social anxiety and persecutory ideation in an experimental situation Psychol Med 38 2008 1121 1132 (Pubitemid 351950157)
46. G. Dorard, S. Berthoz, O. Phan, M. Corcos, and C. Bungener Affect dysregulation in cannabis abusers: a study in adolescents and young adults Eur Child Adolesc Psychiatr 17 2008 274 282
47. D. Freeman, T. Brugha, H. Meltzer, R. Jenkins, D. Stahl, and P. Bebbington Persecutory ideation and insomnia: findings from the second British National Survey of Psychiatric Morbidity J Psychiatr Res 44 2010 1021 1026
48. R.P. Bentall, R. Corcoran, R. Howard, N. Blackwood, and P. Kinderman Persecutory delusions: a review and theoretical integration Clin Psychol Rev 21 2001 1143 1192 (Pubitemid 33033122)
49. N.J. Blackwood, R.J. Howard, R.P. Bentall, and R.M. Murray Cognitive neuropsychiatric models of persecutory delusions Am J Psychiatry 158 2001 527 539 (Pubitemid 32289815)
50. C. Díez-Alegría, C. Vázquez, M. Nieto, C. Valiente, and F. Fuentenebro Personalizing and externalizing biases in deluded and depressed patients: are attributional biases a stable and specific characteristic of delusions? Br J Clin Psychol 45 2006 531 544 (Pubitemid 46017362)
51. S. Mathias, D.I. Lubman, and L. Hides Substance-induced psychosis: a diagnostic conundrum J Clin Psychiatry 69 2008 358 367 (Pubitemid 351549387)
52. R. de Graaf, M. Radovanovic, M. van Laar, B. Fairman, L. Degenhardt, and S. Aguilar-Gaxiola Early cannabis use and estimated risk of later onset of depression spells: Epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative Am J Epidemiol 172 2010 149 159
53. H. Durdle, L.H. Lundahl, C.E. Johanson, and M. Tancer Major depression: the relative contribution of gender, MDMA, and cannabis use Depress Anxiety 25 2008 241 247 (Pubitemid 351499903)
54. D.M. Fergusson, J.M. Boden, and L.J. Horwood Tests of causal links between alcohol abuse or dependence and major depression Arch Gen Psychiatry 66 2009 260 266
55. M. Innamorati, M. Pompili, V. Ferrari, P. Girardi, R. Tatarelli, and A. Tamburello Cannabis use and the risk behavior syndrome in Italian university students: are they related to suicide risk? Psychol Rep 102 2008 577 594